Dermatology
News
Abrocitinib remains effective at 96 weeks, in older as well as younger adults
The analysis stratified patients by age – 18-50 and over 50 years – and found that the sustained improvement with the JAK-1 selective inhibitor as...
News
IL-17 inhibitor approved in Europe for hidradenitis suppurativa
The manufacturer expects a regulatory decision from the U.S. Food and Drug Administration later this year.
News
Dupilumab outcomes stable at end of open label atopic dermatitis study
Other recent research on the biologic has shown that it improves lesional skin barrier function and rapidly reduces the abundance of ...
Conference Coverage
EULAR systemic sclerosis recommendations now include immunosuppressants
The update to 2017 recommendations include targeted synthetic and biologic DMARDs for the first time.
News
SPF is only the start when recommending sunscreens
In a recent study, 43% of dermatologists who responded to a survey reported that they never, rarely, or only sometimes took a patient’s skin type...
News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.
News
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how...
News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
News
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
"Stress can make the skin worse, but at the same time the skin disease and symptoms cause stress," Dr. Peter A. Lio said.
News
Does Ozempic cause hair loss?
“Some of my patients lose hair when they lose weight, generally as a result of the weight loss itself and not as a side effect of these...